I. Krakowski

3.8k total citations · 1 hit paper
108 papers, 1.5k citations indexed

About

I. Krakowski is a scholar working on Oncology, General Health Professions and Anesthesiology and Pain Medicine. According to data from OpenAlex, I. Krakowski has authored 108 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Oncology, 31 papers in General Health Professions and 25 papers in Anesthesiology and Pain Medicine. Recurrent topics in I. Krakowski's work include Health, Medicine and Society (31 papers), Cancer Treatment and Pharmacology (26 papers) and Pain Management and Opioid Use (23 papers). I. Krakowski is often cited by papers focused on Health, Medicine and Society (31 papers), Cancer Treatment and Pharmacology (26 papers) and Pain Management and Opioid Use (23 papers). I. Krakowski collaborates with scholars based in France, United States and Belgium. I. Krakowski's co-authors include B Chevallier, Christine Théodore, Jean-­Marc Ferrero, Gwénaëlle Gravis, Stéphane Oudard, Florence Joly, N. Azli, Henri Roché, Véronique Dièras and Élisabeth Luporsi and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Pain.

In The Last Decade

I. Krakowski

99 papers receiving 1.5k citations

Hit Papers

Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ... 2015 2026 2018 2022 2015 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
I. Krakowski France 18 676 619 287 197 151 108 1.5k
Masaru Narabayashi Japan 28 1.0k 1.5× 881 1.4× 177 0.6× 502 2.5× 278 1.8× 96 2.6k
Corrado Ficorella Italy 27 1.2k 1.7× 651 1.1× 419 1.5× 134 0.7× 273 1.8× 140 2.6k
F Pannuti Italy 23 766 1.1× 233 0.4× 124 0.4× 61 0.3× 142 0.9× 122 1.5k
David A. Decker United States 20 853 1.3× 474 0.8× 360 1.3× 83 0.4× 285 1.9× 57 1.8k
Adnan Aydıner Türkiye 25 1.0k 1.5× 473 0.8× 295 1.0× 97 0.5× 361 2.4× 156 2.3k
John Hanson Canada 19 676 1.0× 272 0.4× 179 0.6× 49 0.2× 192 1.3× 36 1.6k
Peg Esper United States 18 757 1.1× 702 1.1× 124 0.4× 101 0.5× 205 1.4× 30 1.8k
Ahmet Özet Türkiye 19 499 0.7× 301 0.5× 120 0.4× 87 0.4× 144 1.0× 153 1.3k
Paul Craft Australia 23 653 1.0× 278 0.4× 377 1.3× 135 0.7× 236 1.6× 43 1.6k
Judith O. Hopkins United States 22 1.4k 2.1× 650 1.1× 333 1.2× 83 0.4× 210 1.4× 76 2.7k

Countries citing papers authored by I. Krakowski

Since Specialization
Citations

This map shows the geographic impact of I. Krakowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I. Krakowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I. Krakowski more than expected).

Fields of papers citing papers by I. Krakowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I. Krakowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I. Krakowski. The network helps show where I. Krakowski may publish in the future.

Co-authorship network of co-authors of I. Krakowski

This figure shows the co-authorship network connecting the top 25 collaborators of I. Krakowski. A scholar is included among the top collaborators of I. Krakowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I. Krakowski. I. Krakowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Dréno, Brigitte, Kiarash Khosrotehrani, Julie Ryan Wolf, et al.. (2023). The role of dermocosmetics in the management of cancer-related skin toxicities: international expert consensus. Supportive Care in Cancer. 31(12). 672–672. 6 indexed citations
3.
Bouillet, T., et al.. (2022). Activité Physique Adaptée et cancer métastatique : quels besoins et quelles attentes ?. Bulletin du Cancer. 109(12). 1287–1297. 2 indexed citations
4.
Denis, Fabrice & I. Krakowski. (2021). How Should Oncologists Choose an Electronic Patient-Reported Outcome System for Remote Monitoring of Patients With Cancer?. Journal of Medical Internet Research. 23(9). e30549–e30549. 12 indexed citations
5.
Grellety, Thomas, Alain Ravaud, G. Ganem, et al.. (2020). Infection à SARS-CoV-2/COVID 19 et cancers solides : synthèse des recommandations à l’attention des professionnels de santé. Bulletin du Cancer. 107(4). 400–402. 16 indexed citations
7.
Rostaing, S., Sébastien Faure, Nicolas Jovenin, et al.. (2018). La morphine dans le cadre du changement d’opioïdes ou de voie d’administration, chez l’adulte avec une douleur due au cancer. Bulletin du Cancer. 105(11). 1052–1073. 9 indexed citations
8.
Scotté, Florian, Christian Hervé, Jean‐Marc Tourani, et al.. (2017). Supportive Care Organization in France: a national in-depth survey among patients and oncologists. Supportive Care in Cancer. 25(7). 2111–2118. 9 indexed citations
9.
Debieuvre, D., Hugues Morel, Veerle Surmont, et al.. (2017). Cancer cachexia (CAX), anorexia and muscle wasting (sarcopenia) assessment in non-small cell lung cancer (NSCLC): an observational study in 531 patients. Annals of Oncology. 28. v497–v497. 1 indexed citations
10.
Falandry, Claire, I. Krakowski, Hervé Curé, et al.. (2017). Impact of geriatric assessment for the therapeutic decision-making of breast cancer: results of a French survey. AFSOS and SOFOG collaborative work. Breast Cancer Research and Treatment. 168(2). 433–441. 3 indexed citations
12.
Blanchard, Pierre, F. Lesaunier, Nathalie Mesgouez‐Nebout, et al.. (2015). Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial. International Journal of Radiation Oncology*Biology*Physics. 94(1). 85–92. 22 indexed citations
13.
Scotté, Florian, Christian Hervé, Stéphane Oudard, et al.. (2012). Supportive care organisation in France: An in depth study by the French speaking association for supportive care in cancer (AFSOS). European Journal of Cancer. 49(5). 1090–1096. 10 indexed citations
14.
Krakowski, I., et al.. (2009). Enquête observationnelle sur la primoprescription d'antalgiques de palier 3 chez les patients cancéreux. Bulletin du Cancer. 96(spec2). 59–66. 2 indexed citations
15.
Colombat, Philippe, S. Antoun, Régis Aubry, et al.. (2009). À propos de la mise en place des soins de support en cancérologie: pistes de réflexions et propositions. Bulletin du Cancer. 96(spec2). 67–79. 3 indexed citations
16.
Krakowski, I. & P Colombat. (2006). Soins de support en oncologile. Nous sommes tous concernés.. La Revue du praticien. 56(18). 1 indexed citations
17.
Krakowski, I., Nicolas Fabre, Thierry Delorme, et al.. (2005). Recommandations pour la pratique clinique 2005 : Standards, Options et Recommandations pour la prise en charge des douleurs provoquées lors des ponctions lombaires, osseuses et sanguines chez l’adulte atteint de cancer (rapport intégral) ,Validation du rapport original : janvier 2005. Bulletin du Cancer. 92(5). 465–488. 9 indexed citations
18.
Cappelaere, P, B Hecquet, F. Rolland, et al.. (1995). [Randomized placebo trial of myeloprotection with goralatide in patients with squamous cell carcinoma of the upper respiratory and digestive tracts or esophagus, treated with a carboplatin-fluorouracil combination].. PubMed. 82(9). 732–7. 3 indexed citations
19.
Conroy, Thierry, et al.. (1993). Simplified chronomodulated continuous infusion of floxuridine in patients with metastatic renal cell carcinoma. Cancer. 72(7). 2190–2197. 23 indexed citations
20.
Kerbrat, Pierre, Antoine Adenis, Paul Rebattu, et al.. (1993). Phase II study of cystemustine in metastatic colorectal carcinoma. European Journal of Cancer. 29(11). 1597–1599.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026